Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Northwest Biotherapeutics Inc

OTC: NWBO · Life Sciences · 2 alerts · CIK 1072379

Share price
$0.1462Close, Nov 16
Market cap
$265M
Shares outstanding
1.81BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Northwest Biotherapeutics Inc filings on SEC EDGAR ↗

4:36 PM ET 10-Q
Financial Results

Northwest Biotherapeutics Q3 2026 Results: Net Loss of $28.8M, Loss Widens

Northwest Biotherapeutics reported a net loss of $41.1 million for the nine months ended September 30, 2026, an improvement from the $61.6 million loss in the prior year period. Total revenues increased to $2.2 million from $0.7 million, while operating expenses decreased significantly from $47.1 million to $34.6 million.

Key figure
Net loss $28.8M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.